Michigan Cancer Genetics Alliance

News:

Check out our Directory of Cancer Genetic Service Providers in Michigan!

MCGA logoThe MCGA webpage has recently changed. If you need assistance in locating materials or resources, please contact genetics@michigan.gov.

The Michigan Cancer Genetics Alliance (MCGA) is a collaborative network of individuals (including genetics professionals, patient advocates, oncology experts, health plan employees, state and local public health workers, and others) with an interest in cancer genomics. We come together on a biannual basis to discuss the latest issues in cancer genetics and clinical care, research, public health initiatives, genetic counseling and testing, patient needs, advocacy and support availability, and provider education in the state of Michigan. Participation in MCGA is voluntary and there are no fees associated with being a member.

VOLUNTEERS NEEDED FOR RESEARCH STUDIES

For patients affected by HBOC.The ABOUT Network is the first-ever patient-powered research registry created and governed by and for people affected by Hereditary Breast and Ovarian Cancer.

For patients with Lynch Syndrome: Lynch Syndrome chemoprevention. A trial to determine if taking Naproxen (aleve) reduces the risk of colorectal cancer in patients with Lynch Syndrome. This study is currently enrolling patients. To find out if you qualify or for more information, view details here.

For patients with Familial Adenomatous Polyposis (FAP): A double blind, randomized, Phase III Trial of the safety and efficacy of CPP-1X/sulindac compared with CPP-1X/sulindac as single agents in patients with familial adenomatous polyposis (FAP). This study is currently enrolling patients. To find out if you qualify or for more information, view details here or contact the Study Coordinator, Erika Koeppe by email at eskoeppe@med.umich.edu or by phone at (734) 998-1274.